cdmo.directory
← Compare landing

ESTEVE CDMO vs Merck KGaA

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryESTEVE CDMOMerck KGaA
SummaryESTEVE CDMO is adding manufacturing capacity in the USA and China, including a $33 million expansion at its Morton Grove, Illinois site. Its China investment adds three manufacturing workshops with 250 m³ of total reaction volume, and its US assets add early development capabilities.Recent coverage reports that Merck KGaA plans to sell its life science CDMO business to Lonza. The same coverage describes a new €300 million bioprocessing center in Daejeon, South Korea.
ServicesData not yet provided.Data not yet provided.
ModalitiesData not yet provided.Data not yet provided.
Development capabilitiesData not yet provided.Data not yet provided.
Manufacturing capabilitiesData not yet provided.Data not yet provided.
Locations
  • Morton Grove, Morton Grove, Illinois, USA
  • China manufacturing site, China
  • Daejeon Bioprocessing Center, Daejeon, South Korea
CertificationsData not yet provided.Data not yet provided.

Find similar companies

ESTEVE CDMO alternatives · Merck KGaA alternatives

Markdown mirror: /compare/esteve-cdmo/merck-kgaa.md